Document is current
Any future updates will be listed below
-
Authors
Roytman, Gregory R. http://orcid.org/0000-0002-5029-3433
Cutler, Matan
Milligan, Kenneth
Tommasini, Steven M.
Wiznia, Daniel H.
-
Funding
Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1 TR001863)
- License Information
-
More Information
Article History
Received: 6 September 2021
Accepted: 7 September 2022
First Online: 24 September 2022
Declarations
:
: The study was categorized under 45 CFR 46.104(d)(4) and it was determined that the study was exempt from obtaining consent to participate. The name of the ethics committee for approval/consent was Yale IRB – Yale University Institutional Review Board.
: Not applicable.
: The authors disclose that they do not have any competing interests. IsoPlexis Protemic Solution is only the current affiliation of one of our authors and did not have any input, review, or participation in the study.
